These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8064837)

  • 41. Monoclonal antibodies reactive with K1-encapsulated Escherichia coli lipopolysaccharide are opsonic and protect mice against lethal challenge.
    Kaufman BM; Cross AS; Futrovsky SL; Sidberry HF; Sadoff JC
    Infect Immun; 1986 May; 52(2):617-9. PubMed ID: 3516883
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Escherichia coli antibodies in opsonisation and protection against infection.
    van Dijk WC; Verbrugh HA; van Erne-van der Tol ME; Peters R; Verhoef J
    J Med Microbiol; 1981 Nov; 14(4):381-9. PubMed ID: 7031250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endotoxemia in neonatal calves given antiserum to a mutant Escherichia coli (J-5).
    Morris DD; Cullor JS; Whitlock RH; Wickstrom M; Corbeil LB
    Am J Vet Res; 1986 Dec; 47(12):2554-65. PubMed ID: 3541706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The study for the immuno-protection of E. coli O157:H7 outer membrane protein].
    Zhang Y; Lu SQ; Zhang YZ; Zhao BX; Xu JG
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):58-62. PubMed ID: 14990161
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural and functional analysis of orthopoxvirus epitopes with neutralizing monoclonal antibodies.
    Czerny CP; Mahnel H
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2341-52. PubMed ID: 1700065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of subinhibitory levels of antibiotics on expression of Escherichia coli lipopolysaccharide and binding of anti-lipopolysaccharide monoclonal antibodies.
    Nelson D; Delahooke TE; Poxton IR
    J Med Microbiol; 1993 Aug; 39(2):100-6. PubMed ID: 8345504
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bactericidal monoclonal antibodies specific to the lipopolysaccharide O antigen from multidrug-resistant Escherichia coli clone ST131-O25b:H4 elicit protection in mice.
    Szijártó V; Guachalla LM; Visram ZC; Hartl K; Varga C; Mirkina I; Zmajkovic J; Badarau A; Zauner G; Pleban C; Magyarics Z; Nagy E; Nagy G
    Antimicrob Agents Chemother; 2015; 59(6):3109-16. PubMed ID: 25779571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on immunity against Escherichia coli K13 with monoclonal anti-K13 and anti-anti-K13.
    Söderström T; Ohman L; Stein K; Schneerson R; Vann WF; Hanson LA
    Infection; 1985; 13 Suppl 2():S256-9. PubMed ID: 3902658
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of functional activities between IgG1 and IgM class-switched human monoclonal antibodies reactive with group B streptococci or Escherichia coli K1.
    Raff HV; Bradley C; Brady W; Donaldson K; Lipsich L; Maloney G; Shuford W; Walls M; Ward P; Wolff E
    J Infect Dis; 1991 Feb; 163(2):346-54. PubMed ID: 1988519
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibody immunotherapy of gram-negative bacterial sepsis in an immunosuppressed animal model.
    Dunn DL
    Transplantation; 1988 Feb; 45(2):424-9. PubMed ID: 3278438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies on immunity against Escherichia coli K13 with monoclonal anti-K13 and anti-anti-K13.
    Söderström T; Ohman L; Stein K; Schneerson R; Vann WF; Hanson LA
    Infection; 1984; 12(4):309-12. PubMed ID: 6386695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective capacity of antibodies against Escherichia coli and K antigens.
    Kaijser B; Ahlstedt S
    Infect Immun; 1977 Aug; 17(2):286-9. PubMed ID: 70410
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of imipenem on monoclonal antibody-mediated protection against Escherichia coli O18K5.
    Frasa H; Benaissa-Trouw B; Tavares L; van Kessel K; Hustinx W; Schellekens J; Kraaijeveld K; Verhoef J
    Antimicrob Agents Chemother; 1996 Apr; 40(4):999-1004. PubMed ID: 8849267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of protection by two endotoxin-neutralizing IgM monoclonal antibodies in different peritonitis models.
    Hustinx WN; Benaissa-Trouw BJ; Harmsen T; Klein S; Verhoef J; Hoepelman AI; Kraaijeveld K
    J Antimicrob Chemother; 1997 Oct; 40(4):567-72. PubMed ID: 9372427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of mucin and hemoglobin in experimental murine gram-negative bacteremia enhances the immunoprotective action of antibodies reactive with the lipopolysaccharide core region.
    Appelmelk BJ; Verwey-van Vught AM; Maaskant JJ; Schouten WF; Thijs LG; Maclaren DM
    Antonie Van Leeuwenhoek; 1986; 52(6):537-42. PubMed ID: 3545072
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epitope analysis of aztreonam by antiaztreonam monoclonal antibodies and possible consequences in beta-lactams hypersensitivity.
    Shimizu T; Souma S; Nagakura N; Masuzawa T; Iwamoto Y; Yanagihara Y
    Int Arch Allergy Immunol; 1992; 98(4):392-7. PubMed ID: 1384868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rapid detection of enterotoxigenic Escherichia coli O6 in water by using monoclonal antibody and a photon-counting television camera.
    Trevanich S; Miyamoto T; Harada Y; Honjoh K; Hatano S
    J Food Prot; 2000 Apr; 63(4):534-8. PubMed ID: 10772221
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Limited protective effect of rough mutant antisera in murine Escherichia coli bacteremia.
    Peter G; Chernow M; Keating MH; Ryff JC; Zinner SH
    Infection; 1982; 10(4):228-32. PubMed ID: 6752035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibiotics enhance binding of lipid A-specific murine monoclonal antibody E5 to Gram-negative bacteria.
    Bouter AS; van Kessel KP; Cornelissen JJ; Schellekens JF; van der Hoek YY; Snippe H; Verhoef J
    Int J Antimicrob Agents; 1994 Aug; 4(3):191-5. PubMed ID: 18611610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor necrosis factor alpha (TNF-alpha) production in mice immunized with Escherichia coli: correlation with mortality after lethal challenge and production of a native inhibitor of TNF-alpha activity.
    Raponi G; Keller N; Rozenberg-Arska M; Lun MT; Mancini C; Verhoef J
    Infect Immun; 1993 Sep; 61(9):3976-80. PubMed ID: 8359919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.